The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of the PDACai signature in predicting relative benefit from frontline FOLFIRINOX (FFX) and gemcitabine/nab-paclitaxel (GA) for patients (pts) with metastatic pancreatic cancer (mPDAC).
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera; Targeting Resistance in Cancer Cooperative; Tumor Board Tuesday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; IDEAYA Biosciences; Merck; Merus; Novartis; Pfizer; Pionyr; Seagen; TriSalus Life Sciences
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); BioMed Valley Discoveries (Inst); Boehringer Ingelheim (Inst); Hutchison MediPharma (Inst); IDEAYA Biosciences (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); RenovoRx (Inst); Repare Therapeutics (Inst); Seagen (Inst); Takeda (Inst); Tesaro (Inst); Tizona Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm; Use patent for veliparib and FOLFOX
Travel, Accommodations, Expenses - Astellas Pharma
 
Edik Matthew Blais
Employment - AstraZeneca (I); BridgeBio (I); Emerald Cloud Labs (I); HI-Bio (I); Perthera
Leadership - Perthera
Stock and Other Ownership Interests - Perthera
Patents, Royalties, Other Intellectual Property - Named as an inventor on patents filed by Perthera, Inc. (as an employee)
 
Dzung Thach
Employment - Perthera
Stock and Other Ownership Interests - Perthera
 
Jonathan Robert Brody
Stock and Other Ownership Interests - Perthera
Consulting or Advisory Role - Perthera
Travel, Accommodations, Expenses - Perthera
 
Lynn McCormick Matrisian
Other Relationship - Abbvie (Inst); Amgen Foundation (Inst); AstraZeneca (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Corcept Therapeutics (Inst); Covance/LabCorp (Inst); Elevation Oncology (Inst); FibroGen (Inst); Fujifilm (Inst); Genentech (Inst); GlaxoSmithKline (Inst); GRAIL (Inst); Immunovia (Inst); Ipsen (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst); SERVIER (Inst); Takeda (Inst); Tempus (Inst); TriSalus Life Sciences (Inst); TYME (Inst); ViewRay (Inst)
 
David Charles Halverson
Employment - Perthera
Leadership - Perthera
Stock and Other Ownership Interests - Perthera
Research Funding - Bristol-Myers Squibb/Celgene (I); Fate Therapeutics (I); Incyte (I); Janssen (I); Miltenyi Biotec (I); Novartis (I); Takeda (I)
Patents, Royalties, Other Intellectual Property - Perthera multiple patents
 
Patricia DeArbeloa
Employment - Perthera
Leadership - Perthera
Stock and Other Ownership Interests - Perthera
 
Flavio G Rocha
Consulting or Advisory Role - Medtronic
Research Funding - Gunze
Travel, Accommodations, Expenses - Lynx Group
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Celgene; Eisai; Faraday Pharmaceuticals; Ipsen; Merus; Novartis; Pancreatic Cancer Action Network; Perthera; Valar Labs; Varian Medical Systems
Research Funding - Ipsen; NGM Biopharmaceuticals (Inst)
Travel, Accommodations, Expenses - Halozyme
Other Relationship - FibroGen
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Ceres Nanosciences; Perthera; Theralink
Consulting or Advisory Role - Ceres Nanosciences; Perthera; Theralink
Research Funding - Ceres Nanosciences (Inst); Deciphera; G1 Therapeutics (Inst); Genentech (Inst); Mirati Therapeutics (Inst); SpringWorks Therapeutics
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera